SEC Form 4 · accession 0001315406-15-000012
BIO-RAD LABORATORIES, INC. · BIO BIO.B
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christine A Tsingos
Officer — EVP and CFO
Period of report
Mar 12, 2015
Accepted (ET)
Mar 12, 2015 · 8:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000012208
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Bio-Rad A Common Stock | Mar 12, 2015 | M | 3,000 | $88.00 | A | 6,960 | D | |
| Bio-Rad A Common Stock | Mar 12, 2015 | M | 2,400 | $84.57 | A | 9,360 | D | |
| Bio-Rad A Common StockF1 | Mar 12, 2015 | S | 5,400 | $135.94 | D | 3,960 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $88.00 | Mar 12, 2015 | M | 3,000 | D | — | Jun 11, 2018 | Bio-Rad A Common Stock | 3,000 | 0 | D |
| Non-Qualified Stock Option (right to buy)F3 | $84.57 | Mar 12, 2015 | M | 2,400 | D | — | Sep 8, 2020 | Bio-Rad A Common Stock | 2,400 | 600 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.94 to $135.97, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The option vested in five equal annual installments beginning on June 11, 2009.
- F3The option vests over five years at 20% per year on the yearly anniversary date of the grant.